Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Diagnosis, Treatment Response, and Prognosis: The Role of 18F-DOPA PET/CT in Children Affected by Neuroblastoma in Comparison with 123I-mIBG Scan: The First Prospective Study.

Piccardo A, Morana G, Puntoni M, Campora S, Sorrentino S, Zucchetta P, Ugolini M, Conte M, Cistaro A, Ferrarazzo G, Pescetto M, Lattuada M, Bottoni G, Garaventa A, Giovanella L, Lopci E.

J Nucl Med. 2020 Mar;61(3):367-374. doi: 10.2967/jnumed.119.232553. Epub 2019 Sep 20.

PMID:
31541036
2.

Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.

DeCensi A, Puntoni M, Guerrieri-Gonzaga A, Caviglia S, Avino F, Cortesi L, Taverniti C, Pacquola MG, Falcini F, Gulisano M, Digennaro M, Cariello A, Cagossi K, Pinotti G, Lazzeroni M, Serrano D, Branchi D, Campora S, Petrera M, Buttiron Webber T, Boni L, Bonanni B.

J Clin Oncol. 2019 Jul 1;37(19):1629-1637. doi: 10.1200/JCO.18.01779. Epub 2019 Apr 11.

3.

New European Clinical Trial Regulation: perception and expectations in Italy.

Cagnazzo C, Campora S, Ferretti E, Arizio F, Marchesi E.

Ann Oncol. 2017 Jul 1;28(7):1648-1654. doi: 10.1093/annonc/mdx153.

4.

Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer.

Campora S, Campazzi E, Zanardi S, Puntoni M, Piccininno M, Piccardo A, Shoushtari Zadeh Naseri M, Defferrari C, Provinciali N, Petrera M, Marra D, Biscaldi E, Antonucci GC, Ricci D, Clavarezza M, Gennari A, Gozza A, D'Amico M, Mori M, DeCensi A.

Transl Oncol. 2016 Dec;9(6):600-605. doi: 10.1016/j.tranon.2016.08.001. Review.

5.

Multi-Functional Nanogels for Tumor Targeting and Redox-Sensitive Drug and siRNA Delivery.

Adamo G, Grimaldi N, Campora S, Bulone D, Bondì ML, Al-Sheikhly M, Sabatino MA, Dispenza C, Ghersi G.

Molecules. 2016 Nov 23;21(11). pii: E1594.

6.

Prognostic Significance of VEGF after Twenty-Year Follow-up in a Randomized Trial of Fenretinide in Non-Muscle-Invasive Bladder Cancer.

Puntoni M, Petrera M, Campora S, Garrone E, Defferrari C, Torrisi R, Johansson H, Bruno S, Curotto A, DeCensi A.

Cancer Prev Res (Phila). 2016 Jun;9(6):437-44. doi: 10.1158/1940-6207.CAPR-15-0345. Epub 2016 Apr 4.

7.

An observational study of nasal cavity toxicity in cancer patients treated with bevacizumab.

D'Amico M, Pagano M, Pasa A, Puntoni M, Clavarezza M, Gennari A, Gozza A, Zanardi S, Defferrari C, Provinciali N, Campazzi E, Campora S, Paleari L, Marra D, Petrera M, DeCensi A.

Expert Opin Drug Saf. 2014 Nov;13(11):1437-42. doi: 10.1517/14740338.2014.960388. Epub 2014 Sep 16.

PMID:
25224760
8.

Age is predictive of immediate postoperative urinary continence after radical retropubic prostatectomy.

Campodonico F, Manuputty EE, Campora S, Puntoni M, Maffezzini M.

Urol Int. 2014;92(3):276-81. doi: 10.1159/000353414. Epub 2013 Oct 19.

PMID:
24157865
9.

A case series of low dose bevacizumab and chemotherapy in heavily pretreated patients with epithelial ovarian cancer.

Defferrari C, Campora S, D'Amico M, Piccardo A, Biscaldi E, Rosselli D, Pasa A, Puntoni M, Gozza A, Gennari A, Zanardi S, Lionetto R, Bandelloni M, Decensi A.

J Ovarian Res. 2012 Jun 25;5(1):17. doi: 10.1186/1757-2215-5-17.

10.

[Results and considerations on the subject of the use of the "vacuum extractor" in obstetrical practice].

CAMPORA S, SANTANCHE M.

Minerva Ginecol. 1961 Aug 15;13:792-9. Italian. No abstract available.

PMID:
13876100
11.

[Clinical data on the action of a new muscle relaxant in labor].

CAMPORA S.

Minerva Ginecol. 1961 Jun 30;13:631-6. Italian. No abstract available.

PMID:
13690315

Supplemental Content

Loading ...
Support Center